Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.
Oncotype DX Breast Recurrence Score is a prognostic and predictive assay of 21 genes, initially designed for therapy planning in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 vegas golden knights background (HER2)-negative, lymph node-negative or lymph node-positive (maximum 3 nodes involved), early-stage br